RGC: Regencell Corp Company Assets

Symbol and logo of brand Regencell (RGC)

Regencell Bioscience develops treatments for autism and ADHD based on Chinese medicine, minimizing R&D risks. However, its venture status and a narrow niche involving expensive testing constrain growth. The structure of total balance sheet assets clearly demonstrates the firm's resources, where the value of 10.24 serves as a baseline indicator. A lack of pricing power will necessitate aggressive marketing to realize the premium value of future drugs.

RGC: regencellbioscience.com Aggregate Company Assets 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for Regencell (RGC)

- price and consensus price forecast:
Share Price regencellbioscience.com|RGC - Analyst Consensus Forecast
- market capitalization data:
Market Value Regencell Corp|RGC - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Regencell Bioscience|RGC - Company Book Value|Market Value to Book Value regencellbioscience.com|RGC - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital Regencell Bioscience|RGC - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Regencell Corp|RGC - Company Aggregate Debts|Debts to Book Value Regencell Corp
General company analysis:Regencell Bioscience
Finished products of Regencell Corp

Total assets reflect the aggregate value of the company's resources, formed through equity and debt to support operational activities. By analyzing the history of controlled resources, calculated reverse-engineered via ROA, an investor assesses the financial base of Regencell Bioscience (RGC) required for the commercialization of traditional Chinese medicine formulas for the therapy of ADHD and autism spectrum disorders.

Who Regencell Bioscience competes with

biogen.com (BIIB) - Total Business Assets|Company Total Assets NBIX (Neurocrine Biosciences, Inc.)|Company Assets Axsome (AXSM)|Cumulative Company Assets ACAD|Company Total Assets XENE (Xenon Corp)|Aggregate Company Assets Viking Therapeutics|supernus.com - Aggregate Asset Value|CPRX (Catalyst Pharmaceuticals, Inc.) - Aggregate Company Assets|DNLI: Company Assets|Aggregate Company Assets Harmony Pharma HRMY|Biohaven Corp (BHVN) - Aggregate Asset Value|Company Total Assets AMLX (Amylyx Pharmaceuticals)|Company Assets trevitherapeutics.com|PRAX: Company Total Assets|Company Balance Sheet Assets Anavex (AVXL)|CBLL: Company Total Assets|Prothena - Company Assets|Alector Therapeutics (ALEC) - Aggregate Company Assets|ANNX - Total Business Assets|OMER (omeros.com) - Company Total Assets|Neurogene Inc (NGNE) - Cumulative Company Assets|Company Total Assets ACIU (AC Immune Corp)|Company Assets VYGR|Aggregate Company Assets Neumora Therapeutics (NMRA)|Aggregate Company Assets SCLX (scilexholding.com)|Aggregate Company Assets Tevogen Bio TVGN|ACOG - Aggregate Company Assets|Cumulative Company Assets Cognition Therapeutics, Inc. (CGTX)|IKT - Aggregate Asset Value|Cassava Sciences, Inc. (SAVA) - Company Total Assets|Assertio (ASRT) - Aggregate Company Assets|COYA: Company Total Assets|Company Total Asset Base VTGN|Ovid Therapeutics Inc. - Aggregate Company Assets|Company Assets ABOS (Acumen Pharmaceuticals, Inc)|Aggregate Company Assets CRVO|Company Total Asset Base Alterity Therapeutics Ltd. ATHE|CLNN: Company Total Assets|PEPG - Cumulative Company Assets|Jupiter Neurosciences - Company Total Assets|Relmada Corp (RLMD) - Company Total Asset Base|Company Total Assets ANVS (Annovis Bio, Inc.)|Company Assets GRCE|Aggregate Company Assets Firefly Neuroscience AIFF|Total Business Assets anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Company Total Assets|Cumulative Company Assets Reviva Pharmaceuticals, Inc. RVPH|MTVA (MetaVia, Inc.) - Company Total Assets|NRXS: Company Assets|Aggregate Company Assets heliusmedical.com HSDT|Passage Bio (PASG) - Aggregate Asset Value|Neuphoria Therapeutics, Inc. - Company Total Assets|Company Balance Sheet Assets Minerva|Company Total Assets ATHA (Athira Pharma, Inc.)|Cumulative Company Assets ADXN (addextherapeutics.com)|ALZN - Aggregate Company Assets|Total Business Assets Cyclerion Therapeutics Inc. CYCN|PTIX (Protagenic) - Company Total Assets|Pasithea Therapeutics (KTTA) - Company Assets|CRGT: Cumulative Company Assets|ATXI (avenuetx.com) - Company Total Assets|BCLI - Aggregate Company Assets|Aggregate Asset Value CARA|Chromocell Therapeutics Corporation - Aggregate Company Assets|Company Assets ELYM (eliemtx.com)|Aggregate Company Assets Intra-Cellular Therapies, Inc.|Aggregate Asset Value longboardpharma.com LBPH|MRNS (Marinus Pharmaceuticals, Inc.) - Company Total Assets|NKGN - Company Assets|Company Total Assets NRBO (NeuroBo)|Sage Therapeutics Inc (SAGE) - Company Balance Sheet Assets|Company Total Assets SNPX (Synaptogenix, Inc.)|Company Assets TRVN|Aggregate Company Assets Vigil Neuroscience VIGL|Total Business Assets anewmeds.com (WENA)|Cerevel - Company Total Assets